HomeENVB • NASDAQ
Follow
Enveric Biosciences Inc
Previous close
$1.02
Day range
$1.00 - $1.04
Year range
$0.65 - $6.98
Market cap
7.29M USD
Avg Volume
9.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.45M | -39.04% |
Net income | -2.82M | -13.85% |
Net profit margin | — | — |
Earnings per share | -1.60 | 50.68% |
EBITDA | -3.36M | 39.64% |
Effective tax rate | -0.23% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.27M | -79.88% |
Total assets | 6.62M | -78.55% |
Total liabilities | 4.18M | -42.33% |
Total equity | 2.44M | — |
Shares outstanding | 2.32M | — |
Price to book | 0.91 | — |
Return on assets | -105.01% | — |
Return on capital | -235.55% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -2.82M | -13.85% |
Cash from operations | -2.74M | 39.78% |
Cash from investing | 20.00 | 100.11% |
Cash from financing | -105.00K | -101.34% |
Net change in cash | -2.81M | -188.18% |
Free cash flow | -2.16M | 1.68% |
About
Founded
1994
Headquarters
Website
Employees
7